Volibris 5 mg film-coated tablets

Illustration Volibris 5 mg film-coated tablets
Substance(s) Ambrisentan
Admission country United Kingdom
Manufacturer Glaxo Group Ltd.
Narcotic No
ATC Code C02KX02
Pharmacological group Other antihypertensives

Authorisation holder

Glaxo Group Ltd.

Drugs with same active substance

Drug Substance(s) Authorisation holder
Volibris 10 mg film-coated tablets Ambrisentan Glaxo Group Ltd.

Patient’s Leaflet

What is it and how is it used?

Volibris is used to treat pulmonary arterial hypertension (PAH). PAH is high blood pressure in the blood vessels (the pulmonary arteries) that carry blood from the heart to the lungs. In people with PAH, these arteries get narrower, so the heart has to work harder to pump blood through them. This causes people to feel tired, dizzy and short of breath.

Volibris widens the pulmonary arteries, making it easier for the heart to pump blood through them. This lowers the blood pressure and relieves the symptoms.


What do you have to consider before using it?

Don't take Volibris:
  • if you are allergic (hypersensitive) to ambrisentan, soya, or any of the other ingredients of Volibris (listed in Section 6).
  • if you are pregnant, if you are planning to become pregnant, or if you could become pregnant because you are not using reliable birth control (contraception). Please read the information under ?Pregnancy and Breast feeding?.
  • if you are breast feeding.
  • if you have liver disease. Talk to your doctor, who will decide whether Volibris is suitable for you.
  • if you are under 18 years old.

If any of these apply to you:

? Tell your doctor and don?t take Volibris.

Take special care with Volibris:
  • if you have anaemia (a reduced number of red blood cells).

? Tell your doctor, who will decide whether Volibris is suitable for you.

You will need regular blood tests
Before you start taking Volibris, and at regular intervals while you?re taking it, your doctor will take blood tests to check:

  • whether you have anaemia (a reduced number of red blood cells)
  • whether your liver is working properly.

? It is important that you have these regular blood tests for as long as you are taking Volibris.

Signs that your liver may not be working properly include:

  • loss of appetite
  • feeling sick (nausea)
  • being sick (vomiting)
  • high temperature (fever)
  • pain in your stomach (abdomen)
  • yellowing of your skin or the whites of your eyes (jaundice)
  • dark-coloured urine
  • itching of your skin.

If you notice any of these signs:

? Tell your doctor immediately.

Taking other medicines
Tell your doctor or pharmacist if you?re taking any other medicines, if you?ve taken any recently, or if you start taking new ones ?
these include herbal medicines or other medicines you bought without a prescription.

Your doctor may need to adjust your dose of Volibris if you start taking cyclosporine A (a medicine used after transplant or to treat psoriasis).

? Tell your doctor or pharmacist if you are taking this.


Volibris may harm unborn babies conceived before, during or soon after treatment.

? If it is possible you could become pregnant, use a reliable form of birth control (contraception) while you?re taking Volibris. Talk to your doctor about this.

? Don?t take Volibris if you are pregnant or planning to become pregnant.

?If you become pregnant or think that you may be pregnant while you?re taking Volibris, see your doctor immediately.

If you are a woman who could become pregnant, your doctor will ask you to take a pregnancy test before you start taking Volibris and regularly while you are taking Volibris.

If you are a man taking Volibris, it is possible that Volibris may lower your sperm count. Talk to your doctor if you have any questions or concerns about this.


It is not known if Volibris is transferred to breast milk.

?Don?t breast feed while you're taking Volibris. Talk to your doctor about this.

Driving and using machines

It is not known whether Volibris affects your ability to drive or use machines. However, it can cause side effects such as headaches (listed in Section 4), and the symptoms of your condition can also make you less fit to drive.

? Don?t drive or operate machines if you?re feeling unwell.

Important information about some of the ingredients of Volibris

Volibris tablets contain small amounts of a sugar called lactose. If you have an intolerance to lactose or any other sugars:

? Contact your doctor before taking Volibris.

Volibris tablets contain a colouring called Allura red AC Aluminium Lake (E129) which can cause allergic reactions (see Section 4).


How is it used?

Always take Volibris exactly as your doctor has told you to. Check with your doctor or pharmacist if you?re not sure.

How much Volibris to take
The usual dose of Volibris is one 5 mg tablet, once a day. Your doctor may decide to increase your dose to 10 mg, once a day.

If you take cyclosporine A, do not take more than one 5 mg tablet of Volibris, once a day.

How to take Volibris

It is best to take your tablet at the same time each day. Swallow the tablet whole, with a glass of water, do not chew or break the tablet. You can take Volibris with or without food.

Taking out a tablet

These tablets come in special packaging to prevent children removing them.

1. Separate one tablet: tear along the cutting lines to separate one ?pocket? from the strip.
2. Peel back the outer layer: starting at the coloured corner, lift and peel over the pocket.
3. Push out the tablet: gently push one end of the tablet through the foil layer.

If you take more Volibris than you should

If you accidentally take too much Volibris:

? Ask your doctor or pharmacist for advice.

If you forget to take Volibris

If you forget a dose of Volibris, just take the tablet as soon as you remember, then carry on as before.

Don?t take two doses at the same time to make up for a forgotten dose.

Don't stop taking Volibris without your doctor's advice.

Volibris is a treatment that you will need to keep on taking to control your PAH.

?Don?t stop taking Volibris unless you have agreed this with your doctor.


What are possible side effects?

Like all medicines, Volibris can cause side effects, although not everybody gets them.

Very common side effects

These may affect more than one in 10 people:

  • swelling (oedema), especially of the ankles and feet. If you notice this side effect, tell your doctor.
  • headache.
Common side effects

These may affect up to one in 10 people:

  • anaemia (a reduced number of red blood cells), which can cause tiredness, weakness, shortness of breath, and generally feeling unwell
  • a runny or blocked nose, congestion or pain in the sinuses
  • constipation
  • pain in your stomach (abdomen)
  • chest pain or discomfort
  • flushing (redness of the skin)
  • palpitations (fast or irregular heart beats)
  • abnormal blood test results for liver function.
Uncommon side effects

These may affect up to one in 100 people:

  • Allergic reactions. You may notice a rash or itching and swelling (usually of the face, lips, tongue or throat), which may cause difficulty in breathing or swallowing.

? Tell your doctor straight away if you get these effects or if they happen suddenly after taking Volibris.

Some patients may have the following side effects:
  • heart failure (associated with swelling/fluid retention)
  • worsening shortness of breath shortly after starting Volibris.
  • fainting or dizziness
  • low blood pressure
  • feeling sick or being sick (nausea or vomiting)
  • diarrhoea

It is important to have regular blood tests, to check for anaemia and that your liver is working properly. Make sure that you have also read the information in Section 2 under ?You will need regular blood tests? and ?Signs that your liver may not be working properly?.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.


How should it be stored?

Keep out of the reach and sight of children.

Do not use Volibris after the expiry date which is stated on pack and blister.

The expiry date means the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of in wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer require. These measures will help to protect the environment.


Further information

What Volibris contains

The active substance is ambrisentan (5 mg or 10 mg).

The other ingredients are: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, polyvinyl alcohol, talc (E553b), titanium dioxide (E171), macrogol/polyethylene glycol 3350, lecithin (soya) (E322) and Allura red AC Aluminium Lake (E129).

What Volibris looks like and contents of the pack

Volibris 5 mg tablet is a pale pink, square, convex tablet engraved with ?GS? on one face and ?K2C? on the other.

Volibris 10 mg tablet is a deep pink, oval, convex tablet engraved with ?GS? on one face and ?KE3? on the other.

Volibris is supplied as 5 mg and 10 mg film-coated tablets in blister packs of 10 or 30 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Glaxo Group Ltd
Middlesex UB6 0NN
United Kingdom

Glaxo Wellcome GmbH & Co. KG
Bad Oldesloe

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

BelgiëBelgiqueBelgien GlaxoSmithKline s.a.n.v. TélTel 32 02 656 21 11 LuxembourgLuxemburg GlaxoSmithKline s.a.n.v. BelgiqueBelgien TélTel 32 02 656 21 11

Te. 359 2 953 10 34 Magyarország GlaxoSmithKline Kft. Tel. 36 1 225 5300

Malta GlaxoSmithKline Malta Tel 356 21 238131 eská republika GlaxoSmithKline s.r.o. Tel 420 222 001 111 gsk.czmailgsk.com

Danmark GlaxoSmithKline Pharma AS Tlf 45 36 35 91 00 dk-infogsk.com Nederland GlaxoSmithKline BV Tel 31 030 6938100 nlinfogsk.com

Deutschland GlaxoSmithKline GmbH Co. KG Tel. 49 089 36044 8701 produkt.infogsk.com Norge GlaxoSmithKline AS Tlf 47 22 70 20 00 firmapostgsk.no

Eesti GlaxoSmithKline Eesti OÜ Tel 372 6676 900 estoniagsk.com Österreich GlaxoSmithKline Pharma GmbH Tel 43 01 97075 0 at.infogsk.com

GlaxoSmithKline A.E.B.E. 30 210 68 82 100 Polska GSK Commercial Sp. z o.o. Tel. 48 022 576 9000

España GlaxoSmithKline, S.A. Tel 34 902 202 700 es-cigsk.com Portugal GlaxoSmithKline Produtos Farmacêuticos, Lda. Tel 351 21 412 95 00 FI.PTgsk.com

România GlaxoSmithKline GSK S.R.L. Tel 4021 3028 208 France Laboratoire GlaxoSmithKline Tél 33 01 39 17 84 44 diamgsk.com

Ireland GlaxoSmithKline Ireland Limited Tel 353 01 4955000 Slovenija GlaxoSmithKline d.o.o. Tel 386 01 280 25 00 medical.x.sigsk.com

Ísland GlaxoSmithKline ehf. Sími 354 530 3700 Slovenská republika GlaxoSmithKline Slovakia s. r. o. Tel 421 02 48 26 11 11 recepcia.skgsk.com

Italia GlaxoSmithKline S.p.A. Tel 39 045 9218 111 SuomiFinland GlaxoSmithKline Oy PuhTel 358 010 30 30 30 Finland.tuoteinfogsk.com

GlaxoSmithKline Cyprus Ltd 357 22 39 70 00 Sverige GlaxoSmithKline AB Tel 46 08 638 93 00 info.produktgsk.com

Latvija GlaxoSmithKline Latvia SIA Tel 371 67312687 lv-epastsgsk.com United Kingdom GlaxoSmithKline UK Tel 44 0800 221441 customercontactukgsk.com


GlaxoSmithKline Lietuva UAB
Tel: + 370 5 264 90 00

This leaflet was last approved in .


Substance(s) Ambrisentan
Admission country United Kingdom
Manufacturer Glaxo Group Ltd.
Narcotic No
ATC Code C02KX02
Pharmacological group Other antihypertensives



Your personal medicine assistent

afgis-Qualitätslogo mit Ablauf Jahr/Monat: Mit einem Klick auf das Logo öffnet sich ein neues Bildschirmfenster mit Informationen über medikamio GmbH & Co KG und sein/ihr Internet-Angebot: medikamio.com/ This website is certified by Health On the Net Foundation. Click to verify.

Search our database for drugs, sorted from A-Z with their effects and ingredients.


All substances with their common uses, chemical components and medical products which contain them.


Causes, symptoms and treatment for the most common diseases and injuries.

The contents shown do not replace the original package insert of the medicinal product, especially with regard to dosage and effect of the individual products. We cannot assume any liability for the correctness of the data, as the data was partly converted automatically. A doctor should always be consulted for diagnoses and other health questions. Further information on this topic can be found here.